NCT05532332View on ClinicalTrials.gov

Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

February 11, 2021

Study Completion Date

February 11, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Fluoxetine 10 mg capsules

an immediate release hard gelatin capsule containing Fluoxetine hydrochloride equivalent to Fluoxetine 10 mg

DRUG

Prozac® 10 mg capsules

an immediate release hard gelatin capsule containing Fluoxetine hydrochloride equivalent to Fluoxetine 10 mg

Trial Locations (1)

11835

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER

NCT05532332 - Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition | Biotech Hunter | Biotech Hunter